Inventor · disambiguated record
Robert Henk Henning
Also filed as: HENNING ROBERT H · HENNING ROBERT HENK
7 granted patents·10 pending applications·32 citations·filing 2002–2023
79Inventor score
Top patents by PatentIndex Score
17 records- 0179US7335490B2Use of erythropoietin for the preventive or curative treatment of cardiac failureCRUCELL HOLLAND BV·Filed 2003·Granted Feb 26, 2008·27 cites·4 claims
- 0276US10676452B2Compound for the prophylaxis or treatment of organ damageSULFATEQ BV·Filed 2016·Granted Jun 9, 2020·2 cites·2 claims
- 0373US9913841B26-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseasesSULFATEQ BV·Filed 2015·Granted Mar 13, 2018·2 cites·8 claims
- 0467US12156862B2Medicaments for the treatment of vasoconstriction related diseases or disordersSULFATEQ BV·Filed 2018·Granted Dec 3, 2024·1 cites·10 claims
- 0556US2025177384A1Chromanol compounds for treatment or prophylaxis of ageing-associated disordersSULFATEQ BV·Filed 2023·Application pending·0 cites
- 0655US10322124B26-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseasesSULFATEQ BV·Filed 2018·Granted Jun 18, 2019·0 cites·8 claims
- 0753US10426771B26-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseasesSULFATEQ BV·Filed 2018·Granted Oct 1, 2019·0 cites·8 claims
- 0853US2021024485A1Compound for the prophylaxis or treatment of organ damageSULFATEQ BV·Filed 2020·Application pending·0 cites
- 0950US2023330060A1Compounds for treatment of heart failureSULFATEQ BV·Filed 2021·Application pending·0 cites
- 1048US2023202997A1Chromanol, quinone or hydroquinone compounds for treatment of sepsisSULFATEQ BV·Filed 2021·Application pending·0 cites
- 1147US2005119180A1Use of angiotensin 1-7 for enhancing cardiac functionFiled 2004·Application pending·0 cites
- 1246US2023052152A1Compounds for treatment of alzheimer's diseaseSULFATEQ BV·Filed 2020·Application pending·0 cites
- 1340US11730741B26-chromanol derivatives for use as a medicamentSULFATEQ BV·Filed 2018·Granted Aug 22, 2023·0 cites·4 claims
- 1440US2013203830A1Compounds for Prevention of Cell InjuryTALAEI FATEMEH·Filed 2011·Application pending·0 cites
- 1538US2005142130A1Use of angiotensin-(1-7) for preventing and/or reducing the formation of neointimaFiled 2004·Application pending·0 cites
- 1632US2003073237A1Gene therapy to promote angiogenesis and/or the treatment of heart failureFiled 2002·Application pending·0 cites
- 1728US2008161258A1Hsp and Supraventricular ArrhythmiaHENNING ROBERT HENK·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →